SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016069
Filing Date
2023-05-10
Accepted
2023-05-10 08:30:30
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 930811
2 ex10-1.htm EX-10.1 1842
3 ex31-1.htm EX-31.1 17784
4 ex31-2.htm EX-31.2 14618
5 ex32-1.htm EX-32.1 6944
6 ex32-2.htm EX-32.2 6797
7 ex10-1_001.jpg GRAPHIC 765303
8 ex10-1_002.jpg GRAPHIC 413524
  Complete submission text file 0001493152-23-016069.txt   6676573

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE lixt-20230331.xsd EX-101.SCH 40965
10 XBRL CALCULATION FILE lixt-20230331_cal.xml EX-101.CAL 31676
11 XBRL DEFINITION FILE lixt-20230331_def.xml EX-101.DEF 197516
12 XBRL LABEL FILE lixt-20230331_lab.xml EX-101.LAB 328847
13 XBRL PRESENTATION FILE lixt-20230331_pre.xml EX-101.PRE 250800
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 750081
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 23904468
SIC: 2834 Pharmaceutical Preparations